Non-Small Cell Lung Cancer Resection in Lymphoma Patients

Slides:

Advertisements

Similar presentations

Differential Response to Preoperative Chemoradiation and Surgery in Esophageal Adenocarcinomas Based on Presence of Barrett's Esophagus and Symptomatic.

Advertisements

The evolution of treatment outcomes for resected stage IIIA non–small cell lung cancer over 16 years at a single institution Linda W. Martin, MD, Arlene.

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer

History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer Pierre-Benoit Pagès, MD, Pierre Mordant,

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Utility of PET, CT, and EUS to Identify Pathologic Responders in Esophageal Cancer Stephen G. Swisher, MD, Mary Maish, MD, Jeremy J. Erasmus, MD, Arlene.

Joshua E. Rosen, BASc, Hari B

Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: Significance of microscopically positive circumferential radial margins

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Puja Gaur, MD, Wayne L. Hofstetter, MD, B

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population Edmund S. Kassis, MD, Ara A. Vaporciyan,

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes Julie E. Bauman, MD, Michael.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Super-Charged Pedicled Jejunal Interposition Performance Compares Favorably With a Gastric Conduit After Esophagectomy Elizabeth H. Stephens, MD, PhD,

Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy Apar Pataer, MD, PhD, Neda Kalhor,

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Tina Cascone, MD, PhD, Kathryn A. Gold, MD, Stephen G

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Nodal Staging of Stereotactic Ablative Body Radiotherapy Patients Macarena R.

Endoscopic Ultrasound Estimates for Tumor Depth at the Gastroesophageal Junction Are Inaccurate: Implications for the Liberal Use of Endoscopic Resection

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

David C. Rice, MB, BCh, Matthew A

Andrea S. Wolf, MD, MPH, Scott J

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Chris Dickhoff, MD, Max Dahele, MD, PhD, Sayed M

Elizabeth H. Stephens, MD, PhD, Arlene M. Correa, PhD, Min P

Community-Based Multidisciplinary Computed Tomography Screening Program Improves Lung Cancer Survival Daniel L. Miller, MD, William R. Mayfield, MD,

Anthony J. Ascioti, MD, Wayne L. Hofstetter, MD, Michael J

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Shanda H. Blackmon, MD, Arlene M

Who Do You Say You Are? The Annals of Thoracic Surgery

The Role of Consolidation Therapy for Stage III Non-Small Cell Lung Cancer With Persistent N2 Disease After Induction Chemotherapy Arya Amini, BA, Arlene.

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Dhakshina Moorthy Ganeshan, MD, Arlene M

Use of Amiodarone After Major Lung Resection

Outcomes After Extrapleural Pneumonectomy and Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma David C. Rice, MB, BCh, Craig.

Abel Gómez-Caro, MD, Pedro Arguis, MD The Annals of Thoracic Surgery

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Is There a Role for Cancer-Directed Surgery in Early-Stage Sarcomatoid or Biphasic Mesothelioma? Samuel Kim, MD, David A. Bull, MD, Linda Garland, MD,

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Pulmonary Resection for Lung Cancer in Octogenarians

Journal of Thoracic Oncology

Jonathan D. Spicer, MD, PhD, Jitesh B. Shewale, BDS, PhD, David B

Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD,

Management of Primary Pulmonary Artery Sarcomas

Thoracoscopic Bleb Resection Using Two-Lung Ventilation Anesthesia With Low Tidal Volume for Primary Spontaneous Pneumothorax Heezoo Kim, MD, PhD, Hyun.

David C. Rice, MB, BCh, Jeremy J. Erasmus, MD, Craig W

3p22.1 and 10q22.3 Deletions Detected by Fluorescence In Situ Hybridization (FISH): A Potential New Tool for Early Detection of Non-small Cell Lung Cancer.

Visceral Pleural Invasion Is Not Predictive of Survival in Patients With Lung Cancer and Smaller Tumor Size Elizabeth David, MD, Peter F. Thall, PhD,

Predictors of Recurrent Pulmonary Metastases and Survival After Pulmonary Metastasectomy for Colorectal Cancer Shanda H. Blackmon, MD, MPH, Elizabeth.

Mara B. Antonoff, MD, Wayne L. Hofstetter, MD, Arlene M

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer Pamela Samson, MD, Aalok Patel,

Modern Outcome and Risk Analysis of Surgically Resected Occult N2 Non-Small Cell Lung Cancer Hyun Jin Cho, MD, Sung Ryong Kim, MD, Hyeong Ryul Kim, MD,

Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter Joe B Putnam, MD, Garrett L Walsh, MD, Stephen G Swisher,

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Induction Therapy Followed by Surgery for T3-T4/N0 Non-Small Cell Lung Cancer: Long-Term Results Filippo Lococo, MD, Alfredo Cesario, MD, Stefano Margaritora,

Improved Long-Term Outcome With Chemoradiotherapy Strategies in Esophageal Cancer Stephen G. Swisher, MD, Wayne Hofstetter, MD, Ritsuko Komaki, MD, Arlene.

Jenifer L. Marks, MD, Wayne Hofstetter, MD, Arlene M

The risk of second primary tumors after resection of stage I nonsmall cell lung cancer David Rice, MB, BCh, Hyung-Woo Kim, MS, Anita Sabichi, MD, Scott.

Presentation transcript:

Non-Small Cell Lung Cancer Resection in Lymphoma Patients Min P. Kim, MD, Arlene M. Correa, PhD, Stephen G. Swisher, MD, Wayne L. Hofstetter, MD, Reza J. Mehran, MD, David C. Rice, MB, BCh, Garrett L. Walsh, MD, Jeremy Erasmus, MD, Cesar Moran, MD, Ara A. Vaporciyan, MD, Jack A. Roth, MD The Annals of Thoracic Surgery Volume 90, Issue 1, Pages 210-216 (July 2010) DOI: 10.1016/j.athoracsur.2010.02.114 Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 The 5-year overall survival rate for the lymphoma group with lung cancer (35%) was significantly lower than that for the nonlymphoma group with lung cancer (67%; p = 0.04). The Annals of Thoracic Surgery 2010 90, 210-216DOI: (10.1016/j.athoracsur.2010.02.114) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 There was no significant difference in lung cancer-specific survival (p = 0.56). The Annals of Thoracic Surgery 2010 90, 210-216DOI: (10.1016/j.athoracsur.2010.02.114) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 In the lymphoma group, the 5-year overall survival did not differ significantly between patients with active lymphoma at the time of lung cancer resection (active lymphoma) and patients with a history of lymphoma but no active lymphoma at time of lung cancer resection (history of lymphoma; p = 0.07). The Annals of Thoracic Surgery 2010 90, 210-216DOI: (10.1016/j.athoracsur.2010.02.114) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions